Anti-TNFSF13B/BAFF/CD257 Antibody (Tabalumab)
Catalog No.
F1066
Anti-TNFSF13B/BAFF/CD257 Antibody (Tabalumab)
Featured Products
Tabalumab (LY2127399) is a humanized anti-BAFF (B-cell activating factor) monoclonal antibody (IgG4 type) with neutralizing activity against membrane-bound and soluble BAFF. Tabalumab can be used in the research of autoimmune diseases such as rheumatoid arthritis, renal failure and systemic lupus erythematosus.
Quality Control & DataSheet
- View current batch:
-
Purity > 90% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145 kDa
Dry ice
1143503-67-6
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
LY 2127399, LY-2127399
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q9Y275
Human
Unconjugated
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
TNFSF13B / BAFF / CD257
Please avoid freeze-thaw cycles.